Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) shares, rose in value, with the stock price down by -0.08% to the previous day’s close as strong demand from buyers drove the stock to $88.93.
Actively observing the price movement in the recent trading, the stock is buoying the session at $89.0, falling within a range of $87.64 and $94.8. The value of beta (5-year monthly) is 2.301. Referring to stock’s 52-week performance, its high was $89.05, and the low was $40.61. On the whole, RYTM has fluctuated by 33.28% over the past month.
With the market capitalization of Rhythm Pharmaceuticals Inc currently standing at about $5.66 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-07.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 175.49M, with a low estimate of 41.5M and a high estimate of 47.3M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 43.72M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that RYTM’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of RYTM currently trading nearly 34.57% and 39.00% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 82.05, while the 7-day volatility ratio is showing 6.33% which for the 30-day chart, stands at 4.26%. Furthermore, Rhythm Pharmaceuticals Inc (RYTM)’s beta value is 2.36.
A comparison of Rhythm Pharmaceuticals Inc (RYTM) with its peers suggests the former has fared considerably weaker in the market. RYTM showed an intraday change of -0.08% in today’s session so far, and over the past year, it grew by 58.85%%.
Data on historical trading for Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) indicates that the trading volumes over the past 10 days have averaged 1.11 and over the past 3 months, they’ve averaged 706.50K. According to company’s latest data on outstanding shares, there are 63.49 million shares outstanding.
Nearly 8.53% of Rhythm Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 95.48% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 4.76 million shares as on 2025-06-13, resulting in a short ratio of 8.22. According to the data, the short interest in Rhythm Pharmaceuticals Inc (RYTM) stood at 971.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 5.07 million. The stock has risen by 103.21% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the RYTM stock heading into the next quarter.
